Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial - Balar, AV; Galsky, MD; Rosenberg, JE (Lancet, 2017)